Perrigo Company plc Disposal Group, Including Discontinued Operation, Liabilities, Current
Perrigo Company plc (PRGO) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $0 as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2026-08-05
- 2026-06-27: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
- 2026-03-28: Disposal Group, Including Discontinued Operation, Liabilities, Current $28.90M.
- 2025-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $26.80M.
- 2025-09-27: Disposal Group, Including Discontinued Operation, Liabilities, Current $37.40M.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2026-06-27 | $0.00 10-Q · filed 2026-08-05 |
| 2026-03-28 | $28.90M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $26.80M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $37.40M 10-Q · filed 2025-11-05 |
| 2025-03-29 | $4.50M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-28 | $8.20M 10-Q · filed 2024-11-06 |
| 2024-06-29 | $51.50M 10-Q · filed 2024-08-02 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-06 |
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2022-10-01 | $0.00 10-Q · filed 2022-11-08 |
| 2022-07-02 | $0.00 10-Q · filed 2022-08-09 |
| 2022-04-02 | $0.00 10-Q · filed 2022-05-11 |
| 2021-12-31 | $32.90M 10-K · filed 2023-02-28 |
| 2021-10-02 | $29.20M 10-Q · filed 2021-11-12 |
| 2021-07-03 | $468.30M 10-Q · filed 2021-08-11 |
| 2021-04-03 | $450.00M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $419.60M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |